These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 10074131)
41. A packaging cell line for lentivirus vectors. Kafri T; van Praag H; Ouyang L; Gage FH; Verma IM J Virol; 1999 Jan; 73(1):576-84. PubMed ID: 9847362 [TBL] [Abstract][Full Text] [Related]
42. Five recombinant simian immunodeficiency virus pseudotypes lead to exclusive transduction of retinal pigmented epithelium in rat. Duisit G; Conrath H; Saleun S; Folliot S; Provost N; Cosset FL; Sandrin V; Moullier P; Rolling F Mol Ther; 2002 Oct; 6(4):446-54. PubMed ID: 12377185 [TBL] [Abstract][Full Text] [Related]
43. Use of helper-free replication-defective simian immunodeficiency virus-based vectors to study macrophage and T tropism: evidence for distinct levels of restriction in primary macrophages and a T-cell line. Kim SS; You XJ; Harmon ME; Overbaugh J; Fan H J Virol; 2001 Mar; 75(5):2288-300. PubMed ID: 11160732 [TBL] [Abstract][Full Text] [Related]
45. Can the use of HIV-1 derived gene transfer vectors for clinical application be justified? Fuller M; Anson DS Curr Gene Ther; 2004 Mar; 4(1):65-77. PubMed ID: 15032615 [TBL] [Abstract][Full Text] [Related]
46. Replication of human immunodeficiency virus type 1 (HIV-1), simian immunodeficiency virus strain mac (SIVmac) and chimeric HIV-1/SIVmac viruses having env genes derived from macrophage-tropic viruses: an indication of different mechanisms of macrophage-tropism in human and monkey cells. Chen J; Ido E; Jin M; Kuwata T; Igarashi T; Mizuno A; Koyanagi Y; Hayami M J Gen Virol; 1998 Apr; 79 ( Pt 4)():741-5. PubMed ID: 9568969 [TBL] [Abstract][Full Text] [Related]
47. Tropism, intracerebral distribution, and transduction efficiency of HIV- and SIV-based lentiviral vectors after injection into the mouse brain: a qualitative and quantitative in vivo study. Hlavatý J; Tonar Z; Renner M; Panitz S; Petznek H; Schweizer M; Schüle S; Kloke BP; Moldzio R; Witter K Histochem Cell Biol; 2017 Sep; 148(3):313-329. PubMed ID: 28397143 [TBL] [Abstract][Full Text] [Related]
48. Vesicular stomatitis virus glycoprotein- and Venezuelan equine encephalitis virus-derived glycoprotein-pseudotyped lentivirus vectors differentially transduce corneal endothelium, trabecular meshwork, and human photoreceptors. Lipinski DM; Barnard AR; Charbel Issa P; Singh MS; De Silva SR; Trabalza A; Eleftheriadou I; Ellison SM; Mazarakis ND; MacLaren RE Hum Gene Ther; 2014 Jan; 25(1):50-62. PubMed ID: 24125177 [TBL] [Abstract][Full Text] [Related]
49. Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors. Poeschla E; Gilbert J; Li X; Huang S; Ho A; Wong-Staal F J Virol; 1998 Aug; 72(8):6527-36. PubMed ID: 9658096 [TBL] [Abstract][Full Text] [Related]
51. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. Rizvi TA; Panganiban AT J Virol; 1993 May; 67(5):2681-8. PubMed ID: 8474168 [TBL] [Abstract][Full Text] [Related]
52. Development and characterization of a minimal inducible packaging cell line for simian immunodeficiency virus-based lentiviral vectors. Kuate S; Wagner R; Uberla K J Gene Med; 2002; 4(4):347-55. PubMed ID: 12124977 [TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Chang LJ; Urlacher V; Iwakuma T; Cui Y; Zucali J Gene Ther; 1999 May; 6(5):715-28. PubMed ID: 10505094 [TBL] [Abstract][Full Text] [Related]
54. Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus. Kobayashi M; Iida A; Ueda Y; Hasegawa M J Virol; 2003 Feb; 77(4):2607-14. PubMed ID: 12551999 [TBL] [Abstract][Full Text] [Related]
55. Development of a novel trans-lentiviral vector that affords predictable safety. Wu X; Wakefield JK; Liu H; Xiao H; Kralovics R; Prchal JT; Kappes JC Mol Ther; 2000 Jul; 2(1):47-55. PubMed ID: 10899827 [TBL] [Abstract][Full Text] [Related]
56. Effective transduction of primary mouse blood- and bone marrow-derived monocytes/macrophages by HIV-based defective lentiviral vectors. Zeng L; Yang S; Wu C; Ye L; Lu Y J Virol Methods; 2006 Jun; 134(1-2):66-73. PubMed ID: 16430973 [TBL] [Abstract][Full Text] [Related]
57. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector. Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055 [TBL] [Abstract][Full Text] [Related]
58. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Demaison C; Parsley K; Brouns G; Scherr M; Battmer K; Kinnon C; Grez M; Thrasher AJ Hum Gene Ther; 2002 May; 13(7):803-13. PubMed ID: 11975847 [TBL] [Abstract][Full Text] [Related]
59. Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: expression and potential for helper virus-free packaging. Arya SK; Zamani M; Kundra P Hum Gene Ther; 1998 Jun; 9(9):1371-80. PubMed ID: 9650621 [TBL] [Abstract][Full Text] [Related]
60. Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol. Lu X; Humeau L; Slepushkin V; Binder G; Yu Q; Slepushkina T; Chen Z; Merling R; Davis B; Chang YN; Dropulic B J Gene Med; 2004 Sep; 6(9):963-73. PubMed ID: 15352069 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]